Your browser doesn't support javascript.
loading
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.
Carnell, George W; Billmeier, Martina; Vishwanath, Sneha; Suau Sans, Maria; Wein, Hannah; George, Charlotte L; Neckermann, Patrick; Del Rosario, Joanne Marie M; Sampson, Alexander T; Einhauser, Sebastian; Aguinam, Ernest T; Ferrari, Matteo; Tonks, Paul; Nadesalingam, Angalee; Schütz, Anja; Huang, Chloe Qingzhou; Wells, David A; Paloniemi, Minna; Jordan, Ingo; Cantoni, Diego; Peterhoff, David; Asbach, Benedikt; Sandig, Volker; Temperton, Nigel; Kinsley, Rebecca; Wagner, Ralf; Heeney, Jonathan L.
Afiliação
  • Carnell GW; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Billmeier M; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Vishwanath S; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Suau Sans M; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Wein H; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • George CL; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Neckermann P; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Del Rosario JMM; DIOSynVax, Ltd., Cambridge, United Kingdom.
  • Sampson AT; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Einhauser S; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Aguinam ET; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Ferrari M; DIOSynVax, Ltd., Cambridge, United Kingdom.
  • Tonks P; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Nadesalingam A; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Schütz A; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Huang CQ; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Wells DA; DIOSynVax, Ltd., Cambridge, United Kingdom.
  • Paloniemi M; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Jordan I; Applied Science & Technologies, ProBioGen AG, Berlin, Germany.
  • Cantoni D; Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham, United Kingdom.
  • Peterhoff D; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Asbach B; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.
  • Sandig V; Institute of Medical Microbiology & Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.
  • Temperton N; Applied Science & Technologies, ProBioGen AG, Berlin, Germany.
  • Kinsley R; Viral Pseudotype Unit, Medway School of Pharmacy, The Universities of Kent and Greenwich at Medway, Chatham, United Kingdom.
  • Wagner R; Lab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Heeney JL; DIOSynVax, Ltd., Cambridge, United Kingdom.
Front Immunol ; 14: 1118523, 2023.
Article em En | MEDLINE | ID: mdl-36911730
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Suíça